Hyderabad Telangana, India

Vijay Kumar Nyavanandi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Hyderabad, IN (US) (2016)
  • Hyderabad, IN (2017 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations in Oncology: The Patents of Vijay Kumar Nyavanandi

Introduction

Vijay Kumar Nyavanandi, based in Hyderabad, Telangana, India, is an innovative inventor who has made significant contributions to the field of oncology through his patent work. With a total of four patents, Nyavanandi focuses on developing novel compounds to combat diseases characterized by abnormal cellular proliferation, particularly cancer.

Latest Patents

Nyavanandi's latest patents include groundbreaking research on "Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways." The applications provide new quinazolines and azaquinazolines, along with pharmaceutically acceptable salts. These compounds aim to co-regulate important signaling pathways involved in cancer progression by administering a therapeutically effective amount to patients. The potential applications extend to various diseases arising from the dysregulation of these pathways, notably cancer.

Career Highlights

Vijay Kumar Nyavanandi works for Asana Biosciences, LLC, where he applies his expertise in drug development and patent innovation. His work is pivotal in advancing therapeutic options for patients suffering from malignancies. With a strong focus on the pharmaceutical industry, Nyavanandi's inventions enhance the understanding of cancer treatment methodologies.

Collaborations

Throughout his career, Nyavanandi has collaborated with notable colleagues, including Scott Kevin Thompson and Roger Astbury Smith. These partnerships facilitate a multidisciplinary approach to research and development, bolstering the effectiveness of their innovative contributions in medical science.

Conclusion

Vijay Kumar Nyavanandi exemplifies the vital role of inventors in therapeutic innovation, particularly in the realm of oncology. His patents reflect a commitment to enhancing treatment modalities for cancer and other diseases driven by cellular dysregulation. As his research continues to evolve, it holds promise for significant advances in medical treatments and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…